跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEP-1
首页
药物
PEP-1
PEP-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
pET15b-PEP-1-VP3 plasmids, construction method of the pET15b-PEP-1-VP3 plasmids, PEP-1-VP3 fusion protein and expression method of the PEP-1-VP3 fusion protein
申请人: XIAOYAN SHI
优先权: 2011
CN
pET15b-PEP-1-SOD1 plasmid and its construction, PEP-1-SOD1 fusion protein and its expression
申请人: WANG JIANING
优先权: 2007
CN
The pET15b-PEP-1-Cat plasmid and its construction and PEP-1-CAT fusion protein and its expression
申请人: WANG JIANING
优先权: 2005
CN
Application of CD4-PEP-1 in preventing or treating alveolar echinococcosis
申请人: FIRST TEACHING HOSPITAL XINJIANG MEDICAL UNIV
优先权: 2024
CN
Application of CD8-PEP-1 in prevention or treatment of alveolar echinococcosis
申请人: FIRST TEACHING HOSPITAL XINJIANG MEDICAL UNIV
优先权: 2024
CN
PEP-1-G4S-KGF2 fusion protein and coding gene and application thereof
申请人: BEIJING ZHILI SHENGKE TECH CO LTD
优先权: 2020
CN
Method for transducing buffalo embryo by virtue of PEP-1 peptide mediated green fluorescent protein
申请人: GUANGXI ZHUANG AUTONOMOUS REGION BUFFALO RES INST (BUFFALO RES INST OF CHINESE ACAD OF AGRICULTURAL
优先权: 2016
CN
Clostridium perfringens bacteriophage Clo-PEP-1 and use thereof for inhibiting proliferation of clostridium perfringens
申请人: INTRON BIOTECHNOLOGY INC
优先权: 2014
CN
US
2 件公开
药物
反馈